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ABSTRACT
Objectives: the present study was 
designed to evaluate the usefulness of 
intravenous and intrathecal midazolan 
as an adjunct to intrathecal ligdocaine, 
with or without intrathecal fentanyl. 
Methods: double-blind study, 
institutional approval and informed 
consent; 40 patients scheduled for 
minor lumbar orthopedic surgery were 
randomly assigned to one of five groups 
(n=8). Patients were premedicated with 
a 4 mL final intravenous volume (saline 
or midazolan). Spinal anaesthesia was 
administered to a 3 mL final volume – 
75 mg of lidocaina plus either 33 mg 
fentanyl or 500 mg midazolan diluted 
in saline (0,9%) – with the patient 
in sitting position. The latency time 
for onset of the block (LT), time to 
progress to T10 sensory level (TT10), 
duration of the block (Bl), duration of 
effective analgesia (An), the subjective 
degree of intraoperative sedation, level 
of alertness, concentration level and 
degree of anxiety were specifically 
RESUMO
Objetivos: o presente estudo visa 
avaliar a utilidade da administração 
do benzodiazepínico midazolan, por 
via venosa ou espinal, em pacientes 
submetidos a procedimentos cirúrgi-
cos de pequeno porte sob anestesia 
regional com lidocaína e fentanil. 
Métodos: após aprovação do Comitê 
de Ética em pesquisa e consentimen-
to formal, 40 pacientes foram avalia-
dos de forma duplamente encoberta 
e prospectiva, sendo divididos ale-
atoriamente a um dos cinco grupos 
do estudo (n=8). Os pacientes foram 
premedicados com midazolan ou 
solução fisiológica (volume final de 
4 mL) por via venosa. A anestesia es-
pinal foi administrada com o paciente 
sentado, utilizando-se 75 mg de lido-
caína, 33 mg de fentanil ou 500 mg 
de midazolan, diluídos em solução 
fisiológica (0,9%), sendo o volume 
final (3 mL) administrado por via in-
tratecal. Foram avaliados: tempo de 
latência, tempo de bloqueio motor, 
RESUMEN
Objetivos: el presente estudio visa 
evaluar la utilidad de la adminis-
tración del benzodiazepínico mi-
dazolan por vía venosa o espinal 
en pacientes sometidos a procedi-
mientos quirúrgicos de pequeño 
porte sobre anestesia regional con 
lidocaína y fentanil. Métodos: des-
pués de la aprobación del Comité 
de Ética en Investigación Formal, 
40 pacientes fueron evaluados de 
forma doble-ciego y prospectivo, 
siendo divididos de forma aleato-
ria uno de los cinco grupos del es-
tudio (n=8). Los pacientes fueron 
pre-medicados con midazolan o 
solución fisiológica (volumen final 
4 mL) por vía venosa. La anestesia 
espinal fue administrada con el pa-
ciente sentado, utilizándose 75 mg 
de lidocaína, 33 mg de fentanil o 
500 mg de midazolan diluidos en so-
lución fisiológica (0.9%), siendo el 
volumen final administrado por vía 
intratecal 3 mL. Fueron evaluados: 
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measured. P<0.05 was considered 
significant. Results: the addition of 
midazolan to the intrathecal injection 
in the absence of fentanyl was the only 
procedure which caused a statistically 
significant reduction in LT (p<0.002) 
and TT10 (p<0.001). Intrathecal 
midazolan increased the blockade 
time both with (p<0.05) and without 
(p<0.02) intrathecal fentanyl, but, 
when given intravenously, this effect 
failed to reach statistical significance 
(p>0,05). Both intrathecal fentanyl and 
midazolan increased the duration of 
analgesia (p<0.01). With respect to the 
subjective measures, group 1 served 
as the control group, demonstrating an 
alert, fully awake patient who was able 
to concentrate but showed some anxiety. 
Conclusions: while all additional 
treatments resulted in a relaxed patient, 
only those given intrathecal midazolan 
remained fully awake, alert and able to 
concentrate. Intrathecal fentanyl with 
saline premedication or intravenous 
midazolan premedication resulted 
in decreased alertness and inability 
to concentrate, as well as sleepiness, 
which was more extreme in the case 
of those patients given intravenous 
midazolan.
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e grau de ansiedade. Foi considera-
do significante p<0,05. Resultados: 
a adição de midazolan por via in-
tratecal na ausência de fentanil foi 
o único procedimento que resultou 
em redução do tempo de latência 
para início do bloqueio (p<0,002). 
Midazolan por via intratecal aumen-
tou o tempo de bloqueio motor, com 
(p<0,05) ou sem (p<0,02) a associa-
ção de fentanil intratecal, enquanto 
que, ao serem administrado por via 
venosa, não alterou o tempo de blo-
queio motor (p>0,05). Tanto a admi-
nistração de fentanil ou midazolan 
intratecais resultaram em aumento 
do tempo de analgesia (p<0,01). Em 
relação aos resultados subjetivos, 
enquanto o grupo 1 atuou como con-
trole, sendo os pacientes alertas, po-
rém com certo grau de ansiedade, os 
pacientes que receberam midazolan 
estavam alertas e não ansiosos. Con-
clusões: os pacientes que receberam 
midazolan intratecal permaneceram 
acordados, alertas e com capacidade 
de concentração, apresentaram me-
nor latência para anestesia e maior 
tempo de analgesia. 
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el tiempo de latencia, el de bloqueo 
motor, el de analgesia, lo grado de 
sedación y de ansiedad. El p<0.05 
fue considerado significativo. Re-
sultados: la adición de midazolan 
por vía intratecal en la ausencia de 
fentanil fue el único procedimiento 
que resultó en reducción del tiempo 
de latencia para inicio del bloqueo 
(p<0.002). Midazolan por vía intra-
tecal aumentó el tiempo de bloqueo 
motor con (p<0.05) o sin (p<0.02) 
la asociación de fentanil intratecal, 
mientras que administrado por vía 
venosa no cambió el tiempo de blo-
queo motor (p>0.05). Tanto la ad-
ministración de fentanil intratecal 
o midazolan intratecal resultaron 
en aumento del tiempo de analgesia 
(p<0.01). En relación a los resul-
tados subjetivos, el Grupo 1 actuó 
como Control, siendo los pacientes 
alertas, pero con cierto grado de 
ansiedad, mientras los pacientes 
que recibieron midazolan estuvie-
ron alertas y no ansiosos. Conclu-
siones: los pacientes que recibieron 
midazolan intratecal permanecieron 
alertas y con capacidad de concen-
tración, presentaron menor latencia 
para anestesia y mayor tiempo de 
analgesia.  
DESCRIPTORES: Midazolan/
administración & 
dosificación ; Analgesia; 
Lidocaína; Fentanilo; 
Inyecciones espinales
INTRODUCTION
Lamina V-type neurons on the spinal dorsal horn, which 
responded to the bradykinin injection into femoral artery, 
were studied neurophysiologically in spinal transected 
cats by the tungsten microelectrode method. It has been 
demonstrated that the separated and combined antinoci-
ceptive effects of fentanyl, clonidine and midazolan, admi-
nistered intrathecally, can produce reduction in response 
to noxious stimuli. Fentanyl (25 micrograms), clonidine 
(30 micrograms) and midazolan (1 mg), separately, sup-
pressed noxious evoked activity at the spinal level. On the 
other hand, fentanyl (5 micrograms), clonidine (5 micro-
grams) and midazolan (0.5 mg) produced no significant 
suppression of the evoked activity. However, the combi-
nations of drugs at lower doses produced supra-additive 
suppressive effects, which were reversed by each antago-
nist (naloxone, yohimbine and flumazenil). These findin-
gs suggest that, when two of these drugs are combined at 
sub-analgesic doses, a significant synergistic interaction is 
exerted. Therefore, the use of these drugs in combination 
can reduce the total amount of any drug required for anal-
gesia in the spinal cord and also reduce the side effects of 
these agents1-4.
In order to clarify some of these issues, the present 
study was designed to evaluate the usefulness of intrave-
nous and intrathecal midazolan as an adjunct to intrathecal 
ligdocaine with or without intrathecal fentanyl.
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Intrathecal drugs (3.5 ml) Intravenous drugs (4 ml)
CG Ligdocaine (100 mg) + saline Saline
IT-FG Ligdocaine (100 mg) + fentanyl (33 mg) Saline
IT-MG Ligdocaine (100 mg) + midazolan (500 mg) Saline
IV-MG Ligdocaine (100 mg) + saline Midazolam (4 mg)
IT-M+FG Ligdocaine (100 mg) + midazolan (500 mg) + Fentanyl (33 mg) Saline
TABLE 1 - Groups
CG: Control group; IT-FG: Intrathecal fentanyl group; IT-MG: Intrathecal midazolan group; IV-MG: Intravenous midazolan group; IT-M + FG: Intrathecal 
midazolam + Fentanyl group.
Group 1 Group 2 Group 3 Group 4 Group 5
ASA (I/II) 6/2 6/2 7/1 5/3 7/1 NS*
Male/fem. 6/2 5/3 5/3 6/2 5/3 NS
Age (years) 34±9.48 36.75±14.88 33.5±3.69 37.6±8.9 32.25±13.07 NS
Weight (kg) 71.25±7.97 68.75±6.63 64.62±9.41 72.3±11.42 65.05±12.07 NS
Height (cm) 1.71±0.07 1.66±0.1 1.63±0.11 1.72±0.04 1.65±0.09 NS
TABLE 2 - Demographic data 
Values as mean ± STD; *NS: not significant; p>0.05.
METHODS
After Hospital Ethics Committee approval and written 
informed patient consent, 40 ASA status I and II patients, 
scheduled for minor orthopedic lumbar surgery, were 
randomly assigned to one of five groups (n=8) and the 
observer was blind to the treatments. All subjects were 
premedicated in the reception room with a total of 4 mL 
administered intravenously (IV). Spinal anesthesia was 
administered in theatre, with the patient in sitting posi-
tion, using L3-4 interspace and a 25 gauge needle. The 
anesthetic volume of the different anesthetic combina-
tions was 3.5 mL, injected at 1 mL/7 seconds. The pa-
tients laid down (supine position) immediately after com-
pletion of the spinal injection. The groups were divided 
as shown in table 1. A conservative free midazolan solu-
tion was available for this study. Standard monitoring te-
chniques were used, including ECG, blood pressure and 
pulse oximetry.
The latency time for onset of the block (LT) and the 
time to progress to T10 sensory level (TT10), using a 
cold device (cotton soaked in alcohol solution), were re-
corded in seconds. The duration of the block (Bl) was 
measured as the time to reach Bromage 2 score, and the 
duration of effective analgesia (An) measured as the time 
from the intrathecal drug administration to the first need 
for analgesic administration in recovery room, recorded 
in minutes.
The subjective degree of intraoperative sedation was 
recorded as sleepy, slightly sleepy or fully awake. The 
level of alertness was subjectively analyzed by the pa-
tient demeanor, always by the same anesthesiologist. 
Concentration level was measured by the capacity of 
promptly and correctly answering direct questions, like 
“how old are you?”; “how much do you weight?”; “how 
tall are you?”. The correct answers had already been noted 
in the patient’s hospital book. The degree of anxiety was 
also subjectively measured as anxious or relaxed. All ad-
verse effects were recorded and specific treatments were 
available. All patients remained in the anesthetic recovery 
room until apparent complete recovery from anesthesia. 
Groups 4 and 5 were followed for 40 days as outpatients, 
in order to assess any possible adverse effect resulting from 
intrathecal administration of midazolan. Statistical analy-
ses were performed with the ANOVA and the Student’s 
two-tailed t-tests, as required. P<0.05 was considered 
significant.
RESULTS
The five groups did not differ statistically in ASA status, 
male/female ratio, age, weight and height (Table 2). The 
duration of surgery ranged from 45-60 minutes (p>0.05). 
The addition of midazolan to intrathecal injection in the 
absence of fentanyl was the only procedure which caused 
a statistically significant reduction in latency of onset and 
the time to progress to T10, ranging from 80±12 seconds, 
for the control group, to 45±5 seconds for patients who 
received intrathecal midazolan (p<0.002). Intrathecal 
midazolan increased the blockade time compared to the 
control group (46±7 minutes), both with 54±8 minutes 
(p<0.05) and without fentanyl (71±8 minutes; p<0.02), 
but, when given intravenously, this effect failed to rea-
ch statistical significance in the present study (p>0.05). 
Both intrathecal fentanyl and midazolan, by either rou-
te, also significantly increased the duration of analgesia, 
compared to the control group (ranging from mean of 50 
minutes); 70 minutes (spinal fentanyl) to 110 minutes 
(spinal midazolan) (p<0.01). With respect to the subjec-
tive measures (Table 3), group 1 served as the control 
group, demonstrating an alert, fully awake patient who 
was able to concentrate, but showed some anxiety. Whi-
Spinal and intravenous midazolan anesthetic effects on fentanyl/ ligdocaine regional anesthesia following back minor orthopedic surgery
COLUNA/COLUMNA. 2010;9(1):30-34
33
le all additional treatments resulted in a relaxed patient, 
only those given intrathecal midazolan (groups 4 and 5) 
remained fully awake, alert and able to concentrate. Intra-
thecal fentanyl with saline premedication or intravenous 
midazolan premedication resulted in decreased alertness 
and inability to concentrate as well as sleepiness, which 
was more extreme in the case of those patients given in-
travenous midazolan. No intraoperative adverse effects 
were noted, except from five patients (two from group 
2, two from group 3, one from group 4) who scratched 
their nose during the intraoperative period. Groups 4 and 
5 were followed as outpatients for 40 days. No adverse 
effects were noted.
DISCUSSION
In the present study we have clearly demonstrated that 
co-administration of fentanyl and midazolan enhances 
the duration of analgesia associated with a ligdocaine 
spinal block. The fact that the levels and the time to 
achieve analgesia were not influenced by fentanyl agre-
es with the work of others5,6 who used bupivacaine as 
local anaesthetic. The prolongation of spinal local ana-
esthetics action by fentanyl is also in agreement with 
others5, but this effect seems to be much greater if the 
local anaesthetic is ligdocaine. It is interesting to note 
that only intrathecal midazolan, in the absence of fen-
tanyl, significantly reduced the latency and progress of 
the block. It is possible that groups 2 and 3 patients, who 
were sleepy and unable to concentrate, were slow to res-
pond to the stimulus, and thus the measured latency and 
progress times reflected sedation rather than analgesia. 
However, this explanation cannot be applied to group 
4 patients who were alert and able to concentrate. It is 
known that the lipid solubility, and thus the rate of pe-
netration into the spinal cord, is pH dependent for both 
midazolan and ligdocaine. However, the ligdocaine/mi-
dazolan solution had a pH of 6.33 and the addition of 
fentanyl had little effect (pH=6.29), which is unlikely 
to explain the reduced latency observed when fentanyl 
was not added to ligdocaine/midazolan mixture.
The most prominent finding from the subjective data 
revealed that intrathecal midazolan maintains its anxio-
lytic action, without sedating or reducing the ability to 
concentrate. This is desirable when the communication be-
tween the patient and the anesthesiologist, during surgical 
procedures, is important. Nevertheless, studies involving 
midazolan must be carefully carried out, once the dispos-
able formulation is not conservative free. In this study, the 
conservative free midazolan was gently prepared in our 
pharmacy institution.
It has been suggested that midazolan has a mild 
analgesic effect due to central suppression of pain per-
ception7. Other workers have found that IV midazolan 
significantly reduces the affective and motivational 
component of pain, which was experienced by healthy 
human volunteers subjected to experimental pain8. This 
reduction in the motivational drive was suggested to be 
due to a central suppression9. However, in our study, 
the preservation of normal alertness, muscle tonus and 
respiratory rate provide some evidence that the drug 
is acting spinally, rather than by causing a general de-
pression of the central nervous system. However, these 
observations are not objective and have qualitative end 
points10.
Studies of combinations in animals provide some in-
formation that is prerequisite to successful clinical use. 
However, such studies can be hampered, because many 
of the non-opioid drugs have marked effects on motor 
function, which render difficult responses to interpret 
in antinociceptive tests10,11. Nevertheless, midazolan en-
hancement in ligdocaine/fentanyl nociception cannot be 
attributed to the increase in motor deficit in this study. 
The IV midazolan showed no increase in ligdocaine 
motor effect, while enhancing its analgesic effect. In 
addition, although midazolan enhanced both ligdocaine 
motor and analgesic effects, our patients were alert, 
quite able to understand what was happening, to com-
municate and to differentiate a painful sensation even in 
the presence of motor block. In conclusion, putting all 
together, these results demonstrate selective actions on 
BZD and opioid receptor types, with spinal versus corti-
cal distribution. However, a free conservative solution 
must be available before studies can be done to really 
certify its real role in anesthesia, as coadjuvant, mainly 
when an awake – but not anxious – patient is desirable 
during the procedure.
Sedation Alertness Ability to concentrate Anxiety
Group 1 awake good good anxious
Group 2 slightly sleepy poor poor relaxed
Group 3 sleepy poor poor relaxed
Group 4 awake good good relaxed
Group 5 awake good good relaxed
TABLE 3 - Subjetive intraoperative measures 
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